GUARDIAN PHRMCY SERVICES-A (GRDN) Forecast, Price Target & Analyst Ratings

NYSE:GRDN • US40145W1018

Current stock price

35.62 USD
+1.23 (+3.58%)
At close:
36.5 USD
+0.88 (+2.47%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GUARDIAN PHRMCY SERVICES-A (GRDN).

Forecast Snapshot

Consensus Price Target

Price Target
$35.70
+ 0.22% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
$0.20
Revenue Estimate
338.18M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
86.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$35.70
Upside
+ 0.22%
From current price of $35.62 to mean target of $35.70, Based on 10 analyst forecasts
Low
$34.34
Median
$35.70
High
$37.80

Price Target Revisions

1 Month
0.00%
3 Months
2.94%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for GRDN. The average price target is 35.7 USD. This implies a price increase of 0.22% is expected in the next year compared to the current price of 35.62.
The average price target has been revised upward by 2.94% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

GRDN Current Analyst RatingGRDN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

GRDN Historical Analyst RatingsGRDN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
86.00%
GRDN was analyzed by 10 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about GRDN.
In the previous month the buy percentage consensus was at a similar level.
GRDN was analyzed by 10 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-12OppenheimerMaintains Outperform -> Outperform
2026-03-12Truist SecuritiesMaintains Buy -> Buy
2026-01-14Stephens & Co.Maintains Overweight -> Overweight
2025-11-14Truist SecuritiesMaintains Buy -> Buy
2025-10-10OppenheimerInitiate Outperform
2025-09-26Truist SecuritiesMaintains Buy -> Buy
2025-05-19Truist SecuritiesReiterate Buy -> Buy
2025-04-11Truist SecuritiesMaintains Buy -> Buy
2024-11-15Truist SecuritiesMaintains Buy -> Buy
2024-10-22Stephens & Co.Initiate Overweight
2024-10-21Truist SecuritiesInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
$0.20
Revenue Estimate
338.18M
Revenue Q2Q
2.69%
EPS Q2Q
33.74%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
-2.90%
Revenue (3 Months)
-2.90%
EPS (1 Month)
3.51%
EPS (3 Months)
3.51%

Next Earnings Summary

GRDN is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is 0.2 USD and the consensus revenue estimate is 338.18M USD.
The next earnings revenue estimate has been revised downward by 2.9% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
GRDN revenue by date.GRDN revenue by date.
1.046B
15.10%		1.228B
17.42%		1.449B
17.93%		1.442B
-0.46%		1.545B
7.14%		1.69B
9.39%
EBITDA
YoY % growth
GRDN ebitda by date.GRDN ebitda by date.
59.18M
-13.67%		-43.148M
-172.91%		95.036M
320.26%		114.5M
20.48%		127.63M
11.47%		144.62M
13.31%
EBIT
YoY % growth
GRDN ebit by date.GRDN ebit by date.
40.946M
-21.24%		-62.92M
-253.67%		72.701M
215.55%		97.295M
33.83%		106.65M
9.62%		118.47M
11.08%
Operating Margin
GRDN operating margin by date.GRDN operating margin by date.
3.91%-5.12%5.02%6.75%6.90%7.01%
EPS
YoY % growth
GRDN eps by date.GRDN eps by date.
N/AN/A0.77
162.91%		1.06
37.10%		1.19
12.56%		1.42
19.74%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.20
33.74%		0.21
50.57%		0.24
63.20%		0.27
-19.64%		0.25
24.57%		0.27
28.22%		0.31
25.00%		0.33
25.00%
Revenue
Q2Q % growth		338.18M
2.69%		358.25M
4.04%		379.03M
0.42%		389.72M
-1.99%		377.93M
11.75%		391.59M
9.31%		420.48M
10.94%		426.34M
9.40%
EBITDA
Q2Q % growth		25.322M
38.58%		26.501M
13.56%		29.682M
-9.91%		31.532M
-40.61%		26M
2.68%		28.825M
8.77%		34.33M
15.66%		36.512M
15.79%
EBIT
Q2Q % growth		18.544M
42.59%		18.627M
48.07%		21.723M
32.83%		23.454M
-23.76%		19.691M
6.19%		22.517M
20.88%		28.021M
28.99%		30.203M
28.78%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

GRDN Yearly Revenue VS EstimatesGRDN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
GRDN Yearly EPS VS EstimatesGRDN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0 0.5 -0.5 1 -1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
22.71%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
4.81%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
30.11%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

GUARDIAN PHRMCY SERVICES-A / GRDN Forecast FAQ

What do analysts expect the price target to be for GUARDIAN PHRMCY SERVICES-A (GRDN)?

10 analysts have analysed GRDN and the average price target is 35.7 USD. This implies a price increase of 0.22% is expected in the next year compared to the current price of 35.62.

When does GUARDIAN PHRMCY SERVICES-A (GRDN) report earnings?

GUARDIAN PHRMCY SERVICES-A (GRDN) will report earnings on 2026-05-11.

What are the consensus estimates for GUARDIAN PHRMCY SERVICES-A (GRDN) next earnings?

The consensus EPS estimate for the next earnings of GUARDIAN PHRMCY SERVICES-A (GRDN) is 0.2 USD and the consensus revenue estimate is 338.18M USD.

How do analysts rate GUARDIAN PHRMCY SERVICES-A (GRDN)?

The consensus rating for GUARDIAN PHRMCY SERVICES-A (GRDN) is 86 / 100 . This indicates that analysts generally have a positive outlook on the stock.